Elite Diagnostic Limited (JMSE:ELITE)

Elite Diagnostic Revenue

Elite Diagnostic had revenue of 191.55M JMD in the quarter ending December 31, 2025, a decrease of -3.68%. This brings the company's revenue in the last twelve months to 860.95M, up 1.16% year-over-year. In the fiscal year ending June 30, 2025, Elite Diagnostic had annual revenue of 853.82M with 3.96% growth.

• Revenue (ttm): 860.95M
• Revenue Growth: +1.16%
• P/S Ratio: 0.57
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 494.76M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	853.82M	32.54M	3.96%
Jun 30, 2024	821.28M	65.95M	8.73%
Jun 30, 2023	755.33M	131.11M	21.00%
Jun 30, 2022	624.22M	117.31M	23.14%
Jun 30, 2021	506.91M	67.11M	15.26%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 2, 2026

Data Sources Report a data error